Behind the FDA Submission: How J&J Won a Key Approval in AF Ablation

Behind the FDA Submission: How J&J Won a Key Approval in AF Ablation

Submitted by admin on August 22, 2023 - 9:56am
Source: 
Medical Devices and Diagnostics Industry
News Tags: 
JNJ
Medtech
Biosense Webster
FDA
cardiac ablation
Headline: 
Behind the FDA Submission: How J&J Won a Key Approval in AF Ablation
snippet: 

Biosense Webster, part of Johnson & Johnson MedTech, recently scored FDA approval covering several products in its cardiac ablation portfolio for use in for use in a workflow without fluoroscopy.

Do Not Allow Advertisers to Use My Personal information